Different pattern of matrix metalloproteinases expression in alveolar versus embryonal rhabdomyosarcoma

Journal of Pediatric Surgery

Volumn 39, Issue 11, 2004, Pages 1673-1679

  Diomedi Camassei, Francesca ^a   Boldrini, Renata ^a   Ravà, Lucilla ^a   Donfrancesco, Alberto ^a   Boglino, Camillo ^a   Messina, Elisa ^b   Dominici, Carlo ^a   Callea, Francesco ^a  

^a BAMBINO GESÙ CHILDREN S HOSPITAL   (Italy)

^b SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

alveolar; immunohistochemistry; in situ zymography; Matrix metalloproteinases; rhabdomyosarcoma

Indexed keywords

GELATINASE A; GELATINASE B; INTERSTITIAL COLLAGENASE; MATRIX METALLOPROTEINASE; TISSUE INHIBITOR OF METALLOPROTEINASE 1; TISSUE INHIBITOR OF METALLOPROTEINASE 2;

ANTINEOPLASTIC ACTIVITY; ARTICLE; CELL INVASION; CHILD; CONTROLLED STUDY; EMBRYONAL RHABDOMYOSARCOMA; EVALUATION; FEMALE; GENE OVEREXPRESSION; HISTOLOGY; HUMAN; IMMUNOHISTOCHEMISTRY; MALE; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; RHABDOMYOSARCOMA; ZYMOGRAPHY;

ADOLESCENT; CHILD; CHILD, PRESCHOOL; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; INFANT; MALE; MATRIX METALLOPROTEINASES; RHABDOMYOSARCOMA, ALVEOLAR; RHABDOMYOSARCOMA, EMBRYONAL;

EID: 8444239278     PISSN: 00223468     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jpedsurg.2004.07.014     Document Type: Article

References (30)

1. Sternlicht M.D., Werb Z. How matrix metalloproteinases regulate cell behavior. Annu Rev Cell Dev Biol. 17:2001;463-516
2. Stamenkovic I. Matrix metalloproteinases in tumor invasion and metastasis. Semin Cancer Biol. 10:2000;415-433
3. Egebland M., Werb Z. New functions for the matrix metalloproteinases in cancer progression. Nat Rev Cancer. 2:2002;161-174
4. Celiker M.Y., Wang M., Atsidaftos E., et al. Inhibition of Wilms' tumor growth by intramuscular administration of tissue inhibitor of metalloproteinases-4 plasmid DNA. Oncogene. 20:2001;4337-4343
5. Watanabe M., Takahashi Y., Otha T., et al. Inhibition of metastasis in human gastric cancer cells transfected with tissue inhibitor of metalloproteinase 1 gene in nude mice. Cancer. 77:1996;1676-1680
6. Martin D.C., Ruther U., Sanchez-Sweatman O.H., et al. Inhibition of SV40 T antigen-induced hepatocellular carcinoma in TIMP-1 transgenic mice. Oncogene. 13:1996;569-576
7. Jiang Y., Goldberg I.D., Shi Y.E. Complex roles of tissue inhibitors of metalloproteinases in cancer. Oncogene. 21:2002;2245-2252
8. Brand K. Cancer gene therapy with tissue inhibitors of metalloproteinases (TIMPs). Curr Gene Ther. 2:2002;255-271
9. Coussens L.M., Finleton B., Matrisian L.M. Matrix metalloproteinase inhibitors and cancer trials and tribulations. Science. 295:2002;2387-2392
10. Overall C.M., Lopez-Otin C. Strategies for MMP inhibition in cancer Innovation for the post-trial era. Nat Rev Cancer. 2:2002;657-672
11. De Veas R.G., Schweigerer L., Medina M.A. Matrix metalloproteinase-2 and tissue inhibitor of metalloproteinase-2 expression in paediatric tumour cells. Effects of tumour cell proliferation modulators on gelatinolytic activity. J Cancer Res Clin Oncol. 121:1995;275-278
12. Bjornland K., Bratland A., Rugnes E., et al. Expression of matrix metalloproteinases and the metastasis-associated gene S100A4 in human neuroblastoma and primitive neuroectodermal tumor cells. J Pediatr Surg. 36:2001;1040-1044
13. Ara T., Kusafuka T., Inoue M., et al. Determination of imbalance between MMP- 2 and TIMP-2 in human neuroblastoma by reverse-transcription polymerase chain reaction and its correlation with tumor progression. J Pediatr Surg. 35:2000;432-437
14. Ribatti D., Alessandri G., Vacca A., et al. Human neuroblastoma cells produce extracellular matrix-degrading enzymes, induce endothelial cell proliferation and are angiogenic in vivo. Int J Cancer. 77:1998;449-454
15. Ribatti D., Surico G., Vacca A., et al. Angiogenesis extent and expression of MMP-2 and -9 correlate with progression in human neuroblastoma. Life Sci. 68:2001;1161-1168
16. Himelstein B.P., Asada N., Carlton M.R., et al. Matrix metalloproteinase-9 (MMP-9) expression in childhood osseous osteosarcoma. Med Pediatr Oncol. 31:1998;471-474
17. Bodey B., Bodey B. Jr, Siegel S.E., et al. Matrix metalloproteinase expression in childhood astrocytomas. Anticancer Res. 20:2000;3287-3292
18. Bodey B., Bodey B. Jr, Siegel S.E., et al. Matrix metalloproteinase expression in childhood medulloblastomas/primitive neuroectodermal tumors. In Vivo. 14:2000;667-673
19. Kubota S., Ito H., Ishibashi Y., et al. Anti-alpha3 integrin antibody induces the activated form of matrix metalloprotease-2 (MMP-2) with concomitant stimulation of invasion through matrigel by human rhabdomyosarcoma cells. Int J Cancer. 70:1997;106-111
20. Parham D.M. Pathologic classification of rhabdomyosarcomas and correlations with molecular studies. Mod Pathol. 14:2001;506-514
21. Anderson J., Gordon T., McManus A., et al. Detection of the Pax3-FKHR fusion gene in pediatric rhabdomyosarcoma A reproducible predictor of outcome? B J Cancer. 85:2001;831-835
22. Gordon T., McManus A., Anderson J., et al. Cytogenetic abnormalities in 42 rhabdomyosarcoma A United Kingdom cancer cytogenetics group study. Med Pediatr Oncol. 36:2001;259-267
23. Anderson J., Ramsay A., Gould S., et al. PAX3-FKHR induces morphological change and enhances cellular proliferation and invasion in rhabdomyosarcoma. Am J Pathol. 159:2001;1089-1096
24. Epstein J.A., Song B., Lakkis M. Tumor-specific PAX3-FKHR transcription factor, but not PAX3, activates the platelet-derived growth factor alpha receptor. Mol Cell Biol. 18:1998;4118-4130
25. Libura J., Drukala J., Majka M., et al. CXCR4-SDF-1 signaling is active in rhabdomyosarcoma cells and regulates locomotion, chemotaxis, and adhesion. Blood. 100:2002;2597-2606
26. Yoon S.O., Park S.J., Yun C.H., et al. Roles of matrix metalloproteinases in tumor metastasis and angiogenesis. J Biochem Mol Biol. 36:2003;128-137
27. Itoh T., Tanioka M., Yoshida H., et al. Reduced angiogenesis and tumor progression in gelatinase A-deficient mice. Cancer Res. 58:1998;1048-1051
28. Zhou Z., Apte S., Soininen R., et al. Impaired endochondral ossification and angiogenesis in mice deficient in membrane-type matrix metalloproteinase I. Proc Natl Acad Sci U S A. 97:2000;4052-4057
29. Gatto C., Rieppi M., Borsotti P., et al. BAY 12-9566, a novel inhibitor of matrix metalloproteinases with antiangiogenic activity. Clin Cancer Res. 5:1999;3603-3607
30. Shalinsky D.R., Brekken J., Zou H., et al. broad antitumor and antiangiogenic activities of AG3340, a potent and selective MMP inhibitor undergoing advanced oncology clinical trials. Ann NY Acad Sci. 878:1999;236-270